Two novel members of the mouse PRL/GH family have been identified through a search of an expressed sequence tag database. The encoded proteins do not appear to be homologs of other known members of this hormone family. One of these proteins, designated PRLlike protein E (PLP-E), is predicted to be synthesized as a precursor of 265 amino acids, modified by N-linked glycosylation, and secreted as a mature glycoprotein of 236 residues. The second clone encodes a protein of 253 residues with consensus sites for N-linked glycosylation; the secreted form of the protein, designated PRL-like protein F (PLP-F), is predicted to be 223 amino acids in length. Both of these messenger RNAs are expressed specifically in the placenta, with peak levels of PLP-E on days 10 -12 and of PLP-F on days 14 -16. Expression of PLP-E is restricted to the trophoblast giant cells, whereas PLP-F is synthesized only in the spongiotrophoblasts. The genes for both of these proteins map to a 700-kilobase region of mouse chromosome 13 that includes other members of the PRL/GH family. (Endocrinology 138: [5535][5536][5537][5538][5539][5540] 1997) 
T HE PLACENTA of many rodents, ruminants, and primates is a source of hormones in the PRL/GH family. The number of different placental hormones can be quite large; the rat placenta and decidua produce at least nine distinct hormones related to PRL (1) (2) (3) (4) (5) (6) (7) (8) (9) , and seven hormones in this family have been identified in the cow placenta (10 -16) . The synthesis of only four members of this hormone family, placental lactogen I (PL-I), PL-II, proliferin (PLF), and PLF-related protein (PRP), has been discovered in the mouse placenta (17) (18) (19) (20) , but three additional members, PRL-like protein A (PLP-A), PLP-B, and decidual PRL-related protein (dPRP), are reported in the accompanying paper (20a) .
The function and expression of these four mouse placental PRL-like hormones have been studied extensively. PL-I and PL-II bind to the PRL receptor (21, 22) and display PRL-like bioactivities that include stimulating progesterone production by the corpus luteum (23) , inducing insulin secretion (24) , and promoting maternal mammary gland development in preparation for postpartum lactation (25) . PL-I is synthesized specifically in the trophoblast giant cells beginning at the implantation stage (26, 27) , and levels of this hormone messenger RNA (mRNA) and circulating protein peak at midpregnancy (20, 28) . PL-II synthesis also occurs only in the giant cells (29) , but transcription of the PL-II gene begins at midpregnancy and continues at a high level until term (19) .
The other two characterized hormones, PLF and PRP, are, respectively, positive and negative regulators of angiogenesis (30) . Based on an endothelial cell chemotaxis assay, PLF represents the majority of the angiogenic activity released by the midpregnant mouse placenta (30) . This hormone binds to blood vessels in the placenta and fetus (30, 31) and is important for decidual neovascularization (32) . The patterns of PLF and PL-I synthesis are similar, as PLF is produced only by giant cells beginning at the implantation stage (27, 33) , and PLF mRNA and protein both accumulate at a maximum level on day 10 (33). Synthesis of PRP, which is the major antiangiogenic factor secreted by the late pregnant mouse placenta (30) , occurs later in gestation than that of PLF and in both giant cells and spongiotrophoblasts (18, 27, 34) . One role for PRP may be as a temporal brake on the process of neovascularization, but the expression of PRP throughout two cell layers also suggests that PRP may act to establish a zone through which maternal and fetal vessels cannot cross.
As placental hormones related to PRL have important functions during pregnancy, and a number of hormones in this family from other species have not yet been detected in the mouse, we set out to find additional PRL-like hormones that are produced in the mouse placenta. In the accompanying paper (20a), we report on three new mouse hormones that are closely related to proteins that had been identified in the rat. Here, we characterize two additional complementary DNA (cDNA) clones that encode novel members of the mouse PRL/GH family that are expressed specifically in the placenta.
Materials and Methods

Animals and animal care
Pregnant Swiss-Webster mice of defined gestational stages were purchased from Charles River Laboratories (Wilmington, MA). Mice were maintained on days of 14 h of light and 10 h of darkness, with food and water freely available. All procedures were approved by the Northwestern University animal care and use committee. Mouse tissues for RNA analysis were rapidly frozen on dry ice after removal from the animal and stored at Ϫ80 C until use.
Database screening and DNA sequence analysis
An expressed sequence tag (EST) database accessed through the internet at the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-blast?Jform ϭ 0) was searched for sequences related to known members of the mouse PRL family. Retrieved sequences were compared with previously characterized members of the PRL family to identify clones that represent novel mRNAs. Two such clones were identified and obtained from Genome Systems (St. Louis, MO); we have designated these clones PLP-E (EST mo52d02.r1, GenBank no. AA111551, clone identification no. 557187) and PLP-F (EST mh20d02.r1, GenBank no. AA014234, clone identification no. 443043). Plasmid DNAs were purified and sequenced using vector-specific oligonucleotides as primers; primers derived from the ends of the cDNA sequence were then synthesized to generate the remaining sequence. Computer analysis of the sequences was carried out with GeneWorks (Intelligenetics, Mountain View, CA).
RNA and DNA hybridization
Detailed procedures for the analysis of tissue RNA by filter and in situ hybridizations are provided in the accompanying paper (20a). The accompanying paper also describes the isolation and analysis of a yeast artificial chromosome, designated YAC-899, that contains a 700-kilobase (kb) fragment of mouse chromosome 13 that includes most of the genes in the PRL family.
Results
Identification of mouse PLP-E and PLP-F
Two novel cDNA clones closely related to PRL were identified in a mouse conceptus EST database. EST mo52d02.r1 has a single major open reading frame for a 265-amino acid protein (Fig. 1) . Comparison of this protein to mouse PRL and other related hormones establishes that the encoded protein is a novel member of this hormone family (Fig. 3A) , and alignment of the sequences suggests that the first 29 amino acids serve as a secretion signal sequence. The secreted protein of 236 amino acids, which we have designated PLP-E, is likely to be heavily glycosylated, as consensus sites for N-linked glycosylation (Asn-X-Ser/Thr) are present at positions 6, 28, 80, 119, 127, and 234. The major open reading frame begins at the first ATG, and the predicted amino acid sequence is given in italics with residue numbers above; negative numbers refer to the secretion signal sequence, which is predicted to be cleaved between Cys(-1) and Leu(1). The six consensus sites for N-linked glycosylation are marked by asterisks. The consensus sequence for polyadenylation is underlined.
The primary translation product predicted from the second clone, EST mh20d02.r1, is 253 residues, including a signal sequence of 30 amino acids (Fig. 2) . The putative mature protein of 223 amino acids has three potential sites of Nlinked glycosylation (residues 6, 73, and 105). This protein is also significantly similar in sequence to PRL and related hormones (Fig. 3A) , and therefore, we have called it PLP-F. Surprisingly, within this hormone family PLP-E and PLP-F show the greatest degree of sequence similarity with each other (54% identity, a degree of similarity that is much greater than that between any other two family members; Fig. 3A) , suggesting that these two proteins define a new subfamily.
One of the hallmarks of proteins in the PRL family is the occurrence of one large disulfide loop and a small carboxyterminal disulfide loop. Both PLP-E and PLP-F have cysteine residues that align with those found in the other members of the family. In PLP-E, Cys 84 (Fig. 3B) , and these residues may interfere with the formation of the large disulfide loop, similar to what has been found in mouse PL-I (20) . PLP-F is unique among family members in having an extra cysteine (at position 70) immediately adjacent to the upstream conserved cysteine (at position 71) that participates in the large loop.
Expression of PLP-E and PLP-F
Total RNA was isolated from several pregnant mouse tissues, separated by denaturing gel electrophoresis, trans- The major open reading frame begins at the first ATG, and the predicted amino acid sequence is given in italics with residue numbers above; negative numbers refer to the secretion signal sequence, which is predicted to be cleaved between Ser(-1) and Val(1). The three consensus sites for N-linked glycosylation are marked by asterisks. The consensus sequence for polyadenylation is underlined. ferred to a membrane, and hybridized to the PLP-E and PLP-F cDNAs. Expression of both of these cDNAs is restricted to the placental/decidual tissue (Fig. 4) ; in addition to the tissue RNAs shown in Fig. 4 , pituitary RNA was also found to be negative for the PLP-E and PLP-F mRNAs (data not shown). PLP-E synthesis precedes that of PLP-F, with PLP-E mRNA present at high levels in the placenta on days 8 -12 of gestation, and PLP-F mRNA present at maximal levels on days 14 -16 (Fig. 5) . Hybridization to tissue sections reveals that during its peak expression on days 10 and 12 of pregnancy, PLP-E is synthesized only in the trophoblast giant cells (Fig. 6, A and B) . In contrast, PLP-F synthesis is only detected in the spongiotrophoblasts of the day 15 placenta (Fig. 6C) .
Mapping of the PLP-E and PLP-F genes
A yeast artificial chromosome (YAC-899) has been identified with an insert of 700 kb from mouse chromosome 13 that includes the genes for PRL, PL-I, PL-II, PRP, PLP-B, and dPRP (20a) . DNA from the yeast strain carrying YAC-899, but not DNA from a control yeast strain, hybridizes to the PLP-E and PLP-F cDNAs (Fig. 7) . Note that despite the strong sequence similarity between PLP-E and PLP-F (75% at the nucleotide level within the coding region), the two cDNAs do not cross-hybridize under these conditions. Thus, the PLP-E and PLP-F genes also map to the region of chromosome 13 that contains a cluster of genes related to PRL.
Discussion
With the identification of two novel cDNAs, the mouse PRL/GH now has nine known members that are expressed specifically in the placenta or decidua: PL-I, PL-II, PLF, PRP, 
NOVEL PLACENTAL PRL/GH FAMILY MEMBERS
PLP-A, PLP-B, dPRP, PLP-E, and PLP-F. The PLP-E and PLP-F genes along with the genes for PRL, PL-I, PL-II, PRP, PLP-B, and dPRP are located within a 700-kb region at 14.0 centimorgans on mouse chromosome 13 (20a, 35, 36) ; the chromosomal position of the PLP-A gene is not known, and the multicopy PLF genes (37) , although also present on chromosome 13 near this hormone gene cluster (35, 36) , lie outside of this 700-kb region (20a). As PLP-E and PLP-F are most closely related to each other in sequence, with greater than 50% amino acid sequence identity between the secreted proteins and 75% nucleotide sequence identity between the coding regions of the two mRNAs, these two proteins appear to represent a new subclass of PRL-related hormones. Possibly, these genes arose from a more recent duplication event and, consequently, have not diverged as much from each other as have other genes in this family. Alternatively, the sequences of PLP-E and PLP-F have been conserved through selection for continued function of these proteins. Each of these proteins is predicted to be synthesized with a cleavable, hydrophobic secretion signal sequence, and each is expected to be modified by the covalent attachment of carbohydrate at several asparagine residues. Although the four highly conserved cysteine residues in this hormone family are also found in PLP-E and PLP-F, the presence of additional cysteines (one in PLP-E, two in PLP-F) may contribute to a distinct pattern of intramolecular disulfide bonds.
Both PLP-E and PLP-F are expressed specifically in the placenta, but they are synthesized in different cells and at different gestational stages. PLP-E mRNA has only been detected in the trophoblast giant cells, and expression is highest at midpregnancy. The location and timing of PLP-E expression are very similar to patterns of PL-I (20) and PLF (33) synthesis. As transcription of the PL-I and PLF genes is regulated by acti- vating protein-1 (38 -40) and GATA-2/GATA-3 (32, 41) , it seems likely that the PLP-E gene will also be responsive to these transcription factors. PLP-F synthesis is not detected until later in gestation, and only in the spongiotrophoblasts; transcription of the PLP-F gene may, therefore, be regulated similarly to the late gestation expression of PRP (34) and PLP-B (20a) in the spongiotrophoblasts, but the factors regulating transcription of the PRP and PLP-B genes in this cell type are not known.
At present, any biological and physiological functions of PLP-E and PLP-F are speculative. It seems unlikely that PLP-E and PLP-F regulate blood vessel growth, as the majority of angiogenic and antiangiogenic activity secreted by the mouse placenta has already been accounted for by PLF and PRP (30) . Also, because the hormones that bind to the PRL receptor and display PRL-like activity have been purified and identified as PL-I and PL-II (42, 43) , PLP-E and PLP-F probably do not interact with the PRL receptor and do not have lactogenic activity. Therefore, PLP-E and PLP-F may well have novel receptor specificities and effects. However, as PLP-E and PLP-F are closely related in sequence, these two proteins may have similar targets and actions.
